Form 4: KORU Medical Systems CEO Linda Tharby Reports Stock Transaction

Linda Tharby, CEO of KORU Medical Systems, reports disposition of shares to cover tax obligations upon vesting of restricted stock.

Summary

• On April 21, 2025, Linda Tharby, the CEO of KORU Medical Systems, Inc., reported a transaction involving the disposition of 23,587 shares of common stock to cover tax obligations.
• The shares were disposed of at a price of $2.2.
• Following the transaction, Tharby beneficially owns 1,023,163 shares of KORU Medical Systems, Inc.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Future Outlook

The document outlines vesting schedules for restricted stock awards based on future market capitalization and net sales growth targets.

Management Comments

• The filing of this statement shall not be construed as an admission that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement.
• The filing of this statement shall not be construed as an admission that this statement is legally required to be filed by such person.

Industry Context

Form 4 filings are standard disclosures required by the SEC for company insiders, providing transparency into their transactions in the company's stock.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for publicly traded companies, ensuring transparency in insider trading.
• The vesting conditions of the restricted stock awards, based on market capitalization and net sales growth, are common performance-based incentives used by companies to align management's interests with those of shareholders.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the change in ownership by a key executive.
• The vesting of restricted stock awards incentivizes management to achieve market capitalization and net sales growth targets, potentially benefiting shareholders.

Key Dates

Keywords

KORU Medical Systems, Linda Tharby, stock transaction, Form 4, CEO, beneficial ownership, restricted stock, tax obligations